Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MCMICHAEL

Showing results (251-260 of 984) with videos related to

Pageof 99
Sort By:
Health Promotion International|February 20, 2007
Emerging health issues: the widening challenge for population health promotionAnthony J McMichael, Colin D Butler
Lancet (London, England)|May 15, 2007
Greenhouse-gas costs of clinical trialsAnthony J McMichael, Hilary J Bambrick
Nature Immunology|November 28, 2022
Immune signature atlas of vaccines: learning from the good respondersIsabela Pedroza-Pacheco, Andrew J McMichael
Journal of the National Cancer Institute|August 1, 1985
Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancerA J McMichael, J D Potter
Nature Immunology|April 20, 2012
Lessons learned from HIV-1 vaccine trials: new priorities and directionsAndrew J McMichael, Barton F Haynes
American Journal of Clinical Dermatology|November 6, 2013
Acne in patients with skin of color: practical managementNatalie C Yin, Amy J McMichael
American Journal of Preventive Medicine|October 26, 2005
Fish, health, and sustainabilityAnthony J McMichael, Colin D Butler
Current Opinion in Immunology|September 18, 2018
Corrigendum to 'Unusual antigen presentation offers new insight into HIV vaccine design' [Curr Opin Immunol 46 (2017) 75-81]Andrew J McMichael, Louis J Picker
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virusC R Bangham, A J McMichael
The Medical Journal of Australia|November 21, 1988
Oral contraceptive agents and breast cancer: a population-based case-control studyT E Rohan, A J McMichael
Pageof 99

Showing results (251-260 of 984) with videos related to

Sort By:
Pageof 99
Health Promotion International|February 20, 2007
Emerging health issues: the widening challenge for population health promotionAnthony J McMichael, Colin D Butler
Lancet (London, England)|May 15, 2007
Greenhouse-gas costs of clinical trialsAnthony J McMichael, Hilary J Bambrick
Nature Immunology|November 28, 2022
Immune signature atlas of vaccines: learning from the good respondersIsabela Pedroza-Pacheco, Andrew J McMichael
Journal of the National Cancer Institute|August 1, 1985
Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancerA J McMichael, J D Potter
Nature Immunology|April 20, 2012
Lessons learned from HIV-1 vaccine trials: new priorities and directionsAndrew J McMichael, Barton F Haynes
American Journal of Clinical Dermatology|November 6, 2013
Acne in patients with skin of color: practical managementNatalie C Yin, Amy J McMichael
American Journal of Preventive Medicine|October 26, 2005
Fish, health, and sustainabilityAnthony J McMichael, Colin D Butler
Current Opinion in Immunology|September 18, 2018
Corrigendum to 'Unusual antigen presentation offers new insight into HIV vaccine design' [Curr Opin Immunol 46 (2017) 75-81]Andrew J McMichael, Louis J Picker
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virusC R Bangham, A J McMichael
The Medical Journal of Australia|November 21, 1988
Oral contraceptive agents and breast cancer: a population-based case-control studyT E Rohan, A J McMichael
Pageof 99